FDA needs data on new Gardasil use

Merck hit another snag in its efforts to expand the market for its blockbuster cervical cancer vaccine Gardasil. The FDA told the company it wants additional data before deciding whether to approve its use in women ages 27 to 45. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.